Skip to main content
. 2019 Dec 16;25(6):390–396. doi: 10.4103/sjg.SJG_56_19

Table 2.

Expected and observed number of patients with pancreatic cancer (adenocarcinoma) in the cohort adjusted by age, sex, and follow-up period

Patients Expected No. (/105) Observed No. (/105) Relative risk (95% CI)
All 4.30 (232.7) 13 (802.6) 2.62* (1.30-5.29)
Male 3.03 (247.3) 8 (703.5) 3.94* (1.63-9.52)
Female 1.27 (203.9) 5 (653.1) 3.02* (1.72-5.25)

CI: Confidence interval. *Statistically significant